Valeo Pharma Inc
TSX:VPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valeo Pharma Inc
TSX:VPH
|
CA |
|
B
|
BEH-Property Co Ltd
SSE:600791
|
CN |
|
OncoCyte Corp
NASDAQ:OCX
|
US |
|
King Yuan Electronics Co Ltd
TWSE:2449
|
TW |
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
AU |
|
Quadrant Televentures Ltd
BSE:511116
|
IN |
|
Credit Intelligence Ltd
ASX:CI1
|
HK |
|
C
|
Cannabist Company Holdings Inc
NEO:CBST
|
US |
|
A
|
Al-Salam Real Estate Investment Trust
KLSE:ALSREIT
|
MY |
|
G
|
Grown Rogue International Inc
CNSX:GRIN
|
CA |
|
Clean Energy Fuels Corp
NASDAQ:CLNE
|
US |
Bankruptcy Probability
Valeo Pharma Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Valeo Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Valeo Pharma Inc
TSX:VPH
|
4.4m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Valeo Pharma Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Valeo Pharma Inc has total debt of 27.8m CAD. This includes both short-term (3.4m CAD) and long-term (24.4m CAD) debt.
You can find a full breakdown on its Balance Sheet.
